Quicksilver Scientific

Free Shipping on Orders over $99 (Excludes )

Subtotal: 0.00

No products in the cart.

Hista-Aid References

Revised References List HistaAid

  1. Pawanker R, Canonica GW et al. White Book on Allergy 2011-2012 Executive Summary. World Health Organization.
  2. Allergy Overview. Asthma and Allergy Foundation of America. https://www.aafa.org/allergies/. Reviewed September 2015. Accessed September 2022.
  3. Gupta RS, Warren CM et al. Prevalence and severity of food allergies among US adults. JAMA Netw Open. 2019 Jan 4; 2(1): e18563
  4. Simons FE, Simons KJ. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008; 1(9): 145-55.
  5. Greaves MW, Sabroe RA. Histamine: the quintessential mediator. J Dermatol. 1996; 23(11): 735-40.
  6. Fersti R, Akdis C et al. Histamine regulation of innate and adaptive immunity. Front Biosci (Landmark Ed). 2012; 17: 40-53.
  7. Benarroch EE. Histamine in the CNS: multiple functions and potential neurologic implications. Neurology. 2010; 75(16): 1472-9.
  8. Vasoactive Amines. Available at: https://vet.uga.edu/ivcvm/courses/VPAT5200/03_inflammation/04_cmi/cmim02.htm (Accessed June 23, 2019).
  9. Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol. 2006; 147 Suppl 1(Suppl 1): S127–S135.
  10. Krystel-Whittemore M, Dileepan KN et al. Mast Cell: a multi-functional master cell. Front Immunol. 2016; 6: 620.
  11. Pinzer TC, Tietz E et al. Circadian profiling reveals higher histamine plasma levels and lower diamine oxidase serum activities in 24% of patients with suspected histamine intolerance compared to food allergy and controls. Allergy. 2018; 73(4): 949–957.
  12. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007; 85(5): 1185-96.
  13. Frieri M, Patel R et al. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2013 Feb;13(1):27-32
  14. Cingi C, Gevaert P et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. 2017; 7: 17.
  15. Gough H, Grabenhenrich L et al. Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS. Pediatr Allergy Immunol. 2015;26(5):431–437.
  16. Micek J, Jurkova T et al. Quercetin and its anti-allergic immune response. Molecules. 2016; 21(5).
  17. Ueda H, Yamazaki C. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol Pharm Bull. 2002; 25(9): 1197-202.
  18. Amellal M, Bronner C et al. Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta Med. 1980; 51(1): 16-20.
  19. September-Malaterre A et al. Focus on the high therapeutic potentials of quercetin and its derivatives. Phytomedicine Plus. 2022; 2(1): 100220.
  20. Giminez-Bastida JA et al. Targeting mammalian 5-lipoxygenase by dietary phenolics as an anti-inflammatory mechanism: A systematic review. Int J Mol Sci. 2021; 22(15): 7937.
  21. Karuppagounder V, Arumugam S. Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis. Drug Discov Today. 2016; 21(4): 632-9.
  22. Kimata M, Inagaki N et al. Effects of luteolin and other flavonoids on IgE-mediated allergic reactions. Planta Med. 2000; 66(1): 25-9
  23. Kempuraj D, Tagen M et al. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells. Br J Pharmacol. 2008; 155: 1076–84.
  24. Kimata M, Shichijo et al. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy. 2000; 30:501–8.
  25. Seelinger G, Merfort I et al. Anti-oxidant, anti-inflammatory and antiallergic activities of luteolin. Planta Med. 2008: 74, 1667–1677.
  26. Kazmierczak-Baranska J et al. Two faces of vitamin C—antioxidative and pro-oxidative agent. Nutrients. 2020; 12(5): 1501.
  27. Hagel AF, Layritz CM. Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases. Naunyn Schmiedebergs Arch Pharmacol. 2013; 386: 789-793.
  28. Jarisch R et al. Influence of orally taken vitamin C on histamine levels and motion sickness.
  29. Jiang L, Diaz PT et al. Molecular characterization of redox mechanisms in allergic asthma. Ann Allergy Asthma Immunol. 2014; 113: 137–142.
  30. Fogarty A, Lewis SA et al. Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomized trial. Respir Med. 2006; 100(1): 174-179.
  31. Vollbracht C, Rathel M. Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long-term observational study J Int Med Res. 2018; 46(9): 3640-3655.
  32. Hagel AF, Layritz CM et al. Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases. Arch Pharmacol. 2013; 386: 789–793.
  33. Keum YS. Regulation of Nrf2-mediated phase II detoxification and anti-oxidant genes. Biomol Ther (Seoul). 2012; 20(2): 144-151.
  34. Hu B et al. Nuclear factor E2 related factor (NRF2) inhibits mast cell-mediated allergic inflammation via SIRT4-mediated mitochondrial metabolism. Annals of Palliative Medicine. 2020; 9(6).
  35. Rajora S, Suriano R. et al. 3,30 -Diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study. Thyroid. 2011(21): 3; 299-304.
  36. Bonds RS, Midoro-Horiuti T. Estrogen effects in allergy and asthma. Curr Opin Allergy Clin Immunol. 2013; 13(1): 92–99.
  37.  Zierau O, Zenclussen AC et al. Role of female sex hormones, estradiol, and progesterone, in mast cell behavior. Front Immunol. 2012; 3: 169. 
  38. Bódis J1, Tinneberg HR et al. The effect of histamine on progesterone and estradiol secretion of human granulosa cells in serum-free culture. Gynecol Endocrinol. 1993; 7(4): 235-9.  
  39. Ernst IM, Schuemann C et al. 3,3′-Diindolylmethane but not indole-3-carbinol activates Nrf2 and induces Nrf2 target gene expression in cultured murine fibroblasts. Free Radic Res. 2011; 45(8): 941-9. 
  40. Anderton MJ, Manson MM et al. Physiological modeling of formulated and crystalline 3,3′-diindolylmethane pharmacokinetics following oral administration in mice. Drug Metab Dispos. 2004 Jun;32(6):632-8. 
  41. Shiue I. Is abnormal liver function correlated with food sensitization in adults? US NHANES, 2005–2006. Allergol Immunopathol. 2015; 43(4): 361-368.
  42. Ferreira-Silva M, et al. Quercetin Liposomal nanoformulation for ischemia and reperfusion injury treatment. Pharmaceutics. 2022; 14(1): 104.
  43. Taheri Y, et al. Paving luteolin therapeutic potentialities and agro-food-pharma applications: emphasis on in vivo pharmacological effects and bioavailability traits. Oxid Med Cell Longev. 2021; 1987588.  
  44. Gopi S and Balakrishnan P. Evaluation and clinical comparison studies on liposomal and non-liposomal ascorbic acid (vitamin C) and their enhanced bioavailability. J Liposome Res. 2020; 356-364.  
    Your Cart
    You're 99.00 away from free shipping.
    Your cart is empty
      Calculate Shipping
      Apply Coupon

      to your account for access to our

      Memorial Day

      Weekend Sale!

      Don’t have an account? Sign up here!